Related Experiment Video
Updated: May 21, 2025
Rapid Viscoelastic Characterization of Airway Mucus Using a Benchtop Rheometer
Published on: April 21, 2022
Association Between Airway Mucus Plugs and Risk of Moderate-to-Severe Exacerbations in Patients With COPD: Results
Xueping Li1, Shengchuan Feng1, Yuqiong Yang1
1Department of Respiratory and Critical Care Medicine, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
Background:
Airway mucus plugs are frequently identified on CT scans of patients with COPD and are associated with worse airflow obstruction and higher mortality. However, the association between airway mucus plugs and the risk of acute exacerbation of COPD (AECOPD) has not been extensively studied.
Research Question:
Are airway mucus plugs associated with the risk of future moderate-to-severe AECOPD?
Study Design And Methods:
In this prospective cohort study, we identified airway mucus plugs on CT scans of patients with COPD. Mucus plugs were scored from 0 to 18 based on the number of pulmonary segments affected and categorized into 3 groups (0, 1-3, and ≥ 4). Patients were followed for 2 years. Negative binomial regression and Cox regression were used to model the association between airway mucus plugs and moderate-to-severe AECOPD, adjusting for potential confounders.
Results:
Among the 194 patients with COPD, 22%, 35%, and 43% had mucus plugs in 0, 1 to 3, and ≥ 4 pulmonary segments, respectively. During the following year, 30% of patients experienced at least 1 moderate-to-severe AECOPD, with an incidence of 12%, 25%, and 44% for patients with 0, 1 to 3, and ≥ 4 pulmonary segments with mucus plugs, respectively. In negative binomial regression, each 1-point increase in airway mucus plug score was associated with an 8.3% higher risk of moderate-to-severe exacerbation (incidence rate ratio, 1.08; 95% CI, 1.01-1.16; P = .028). In multivariate Cox regression, mucus plugs in ≥ 4 vs 0 and ≥ 4 vs 1 to 3 pulmonary segments were associated with hazard ratios of moderate-to-severe exacerbation of 5.02 (95% CI, 1.84-13.75; P = .002) and 2.32 (95% CI, 1.25-4.33; P = .008), respectively. Consistent results were observed in the subset of patients completing the 2-year follow-up (n = 150).
Interpretation:
In patients with COPD, airway mucus plugs were shown to be associated with increased future risk of subsequent moderate-to-severe AECOPD.
Clinical Trial Registration:
International Clinical Trials Registry; No.: NCT03240315; URL: https://www.who.int/clinical-trials-registry-platform.
More Related Videos
04:03Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
Published on: September 27, 2024
05:19Author Spotlight: An Effective Traditional Chinese Medicinal Treatment for Chronic Obstructive Pulmonary Disease with Abdominal Distension
Published on: September 1, 2023
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
01:22Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:29Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
01:26COPD: Management Using Bronchodilators and Corticosteroids
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
01:23Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...